Category: Drug Discovery
Europe Drug Discovery
-
Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) Tailored Hormone Therapies Gain Momentum The global compounded bioidentical hormone therapy market is rapidly advancing, offering tailored hormone treatments with a multitude of applications. These therapies, utilizing bioidentical hormones, are anticipated to bring forth ... Read More
-
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
... (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest ... Read More
-
Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a condition characterized by inflammation or swelling of the sinuses, has become a notable healthcare challenge, causing discomfort and decreased quality of life for patients. The condition, which often presents symptoms such as nasal congestion, ... Read More
-
Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Afric
... The global drug discovery informatics market is experiencing robust growth due to increased investments in novel research and development initiatives by pharmaceutical companies. A significant portion of time and financial resources is dedicated to drug ... Read More
-
Toxoplasmosis Treatment Market by Type (Acquired Toxoplasmosis and Congenital Toxoplasmosis), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies and Online Providers) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... RoW)-Forecast up to 2027 Toxoplasmosis is an infection caused due to a common parasite, which is present in cat feces and in contaminated food. This parasite is referred as Toxoplasma gondii. The symptoms of toxoplasmosis ... Read More
-
Dystonia Drugs Market by Drug Type (Anticonvulsants drugs, Others, Dopaminergic agents and GABAergic agents), Route of Administration (Oral and Injectable), Distribution Channel (Hospital Pharmacies, Online Providers and Drug Stores and Retail Pharmacies) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... America, Europe, APAC and RoW) - Forecast up to 2027 Dystonia can be referred to a movement disorder featured by involuntary muscle contractions which cause slow repetitive movements or abnormal postures. These muscle contractions result ... Read More
-
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
... Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032 INTRODUCTION Since the approval of the ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
... Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035 Clinical trials form an integral ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Artificial Intelligence in Healthcare Market Assessment, By Component [Hardware, Software and Services], By Technology [Machine Learning (ML), Natural Language Processing (NLP), Context-Aware Computing, Robotic Process Automation (RPA), Computer Vision and Others], By Application [Robot-Assisted Surgery, Administrative Workflow Assistance, Cybersecurity, Virtual Nursing Assistant, Clinical Trials, Diagnosis, Customer Service Chatbots, Drug Discovery and Others], By End-user [Hospitals & Clinics, Pharmaceutical & Biotechnology, Patients and Others], By Region [North America, Europe, Asia Pacific, Middle East & Africa and South America]
... Administrative Workflow Assistance, Cybersecurity, Virtual Nursing Assistant, Clinical Trials, Diagnosis, Customer Service Chatbots, Drug Discovery and Others], By End-user [Hospitals & Clinics, Pharmaceutical & Biotechnology, Patients and Others], By Region [North America, Europe, Asia Pacific, ... Read More
-
Drug Discovery Services Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Chemistry Services, Biology Services); By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization); By Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Drug Type (Biologics, Small Molecule Drugs); By Therapeutic Area (Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Oncology, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Region (North America, Europe, ... Read More
-
France Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the France market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More
-
Global Hidradenitis Suppurativa Market: Analysis By Patients, By Drugs (Povorcitinib, Bimekizumab, Sonelokimab), By Region Size (The US, Europe, Rest of the World) & Forecast with Impact Analysis of COVID-19 and Forecast up to 2030
... Suppurativa, according to the National Organization of Rare Disorders, is a chronic disorder characterized by swelling, painful lesions in the armpit, groin, anal, and breast regions. It is a painful and long-term skin ailment that ... Read More
-
Europe Gabapentin Market Size, Share & Industry Trends Analysis Report By Application (Epilepsy, Restless Legs Syndrome, Neuropathic Pain), By Dosage Form (Capsule, Tablet and Oral Solution), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028
... - 2028 The Europe Gabapentin Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028). A persistent brain disorder that is not contagious. It is characterized by recurring seizures, which are brief ... Read More
-
France Migraine Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the migraine therapeutics market are highlighted in the study. ... Read More
-
Germany Migraine Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Germany market. Also, factors that are driving and restraining the migraine therapeutics market are highlighted in the study. ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Cell Surface Markers Detection Market, By Product (Flow Cytometry, Hematology Analysers, Cell Imaging Systems, Reagents and Kits, and Other Products), By Application (Disease Diagnosis and Identification, Drug Discovery, and Other – Research and Academia Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Cell surface markers detection refers to separation and identification of target cells ... Read More
-
m-RNA Synthesis Service Market, By Application (Therapeutic Development, Vaccine Production, Drug Discovery, Others), By Scale of Operation (Research, Commercial), By End User (Biopharmaceutical Companies, Contract research organizations (CROs), Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information ... Read More
-
Europe Liver Cancer Therapeutics Market - 2023-2030
... a CAGR of 8.95% during the forecast period (2023-2030). Liver cancer is a chronic, life-threatening, advanced condition that initiates in liver cells. The liver is the critical organ in the human body, found in the ... Read More
-
Europe Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... and the increasing prevalence of diseases. Key Highlights Another driving factor is the increasing focus on rare diseases and multiple orphan drugs in the pipeline. As rare diseases have considerably low prevalence rate, as compared ... Read More
-
Denmark Pharmaceutical Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... biotech companies are concentrating their research & development departments on finding new compounds or leads for the treatment of this disease, which is in the last stages of clinical trials, as a result of the ... Read More
-
Alzheimer’s disease diagnostics and therapeutics Market, by Product (Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Others) and Diagnostics (Brain Imaging, CSF Test for Alzheimer’s Disease)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Alzheimer’s disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of dementia, a continuous decline ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
-
Europe Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
... overactive bladder treatment market is expected to grow from US$ 1,111.05 million in 2022 to US$ 1,318.55 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028. Growing ... Read More
Research Assistance
